[When is surgical resection of the primary tumor indicated in metastatic prostate cancer and what is the scientific rationale?]

Urologe A. 2017 May;56(5):591-594. doi: 10.1007/s00120-017-0359-7.
[Article in German]

Abstract

Similar to other tumour entities, analyses of cancer databases giving hope that patients with advanced prostate cancer with osseous metastases benefit from cytoreductive surgery. Prospective clinical trials are in the process of proving this hypothesis. This review article focuses on molecular genetic pathways and clinical data.

Keywords: Bone metastasis; Cytoreductive treatment; Lymph nodes; Metastases; Prostatectomy, radical.

Publication types

  • Review

MeSH terms

  • Carcinoma / mortality*
  • Carcinoma / pathology
  • Carcinoma / surgery*
  • Evidence-Based Medicine
  • Humans
  • Lymphatic Metastasis
  • Male
  • Neoplasm Recurrence, Local / mortality*
  • Neoplasm Recurrence, Local / prevention & control
  • Prevalence
  • Prostatectomy / mortality*
  • Prostatectomy / statistics & numerical data*
  • Prostatic Neoplasms / mortality*
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / surgery*
  • Survival Rate
  • Treatment Outcome